70
Views
1
CrossRef citations to date
0
Altmetric
OTONEUROLOGY

Effect of topical use of mitomycin C and 5-fluorouracil on the closure time of myringotomies created by radiofrequency unit

, MD, &
Pages 1212-1216 | Received 07 Oct 2008, Published online: 08 Oct 2009

References

  • Bluestone CD. Role of surgery for otitis media in the era of resistant bacteria. Pediatr Infect Dis J 1998; 17: 1090–8
  • Mandel EM, Rockette HE, Bluestone CD, Paradise JL, Nozza RJ. Efficacy of myringotomy with and without tympanostomy tubes for chronic otitis media with effusion. Pediatr Infect Dis J 1992; 11: 270–7
  • Handler SD. Current indications for tympanostomy tubes. Am J Otolaryngol 1994; 15: 103–8
  • Morris MS. Tympanostomy tubes types, indications, technique, and complications. Otolaryngol Clin North Am 1999; 32: 385–90
  • Kay DJ, Nelson M, Rosenfeld RM. Meta-analysis of tympanostomy tube sequelae. Otolaryngol Head Neck Surg 2001; 124: 374–80
  • Silverstein H, Kuhn J, Choo D, Krespi YP, Rosenberg SI, Rowan PT. Laser-assisted tympanostomy. Laryngoscope 1996; 106: 1067–74
  • Lau P, Shelton C, Goode RL. Heat myringotomy. Laryngoscope 1985; 95: 38–42
  • Estrem SA, Batra PS. Preventing myringotomy closure with topical mitomycin C in rats. Otolaryngol Head Neck Surg 1999; 120: 794–8
  • Yucel OT. Topical use of mitomycin C in laser myringotomy: an experimental study in rats. Int J Pediatr Otorhinolaryngol 2000; 54: 93–6
  • Cakir BO, Dadaş B, Başak T, Cinar U, Ozdoğan HC, Uslu B, et al. Effect of topical 5-fluorouracil on closure time of myringotomies created by a radiofrequency surgical unit in guinea pigs. Otol Neurotol 2002; 23: 146–51
  • Lachanas VA, Prokopakis EP, Malandrakis SG, Hajiioannou JK, Christodoulou PN, Velegrakis GA. Radiofrequency myringotomy with the topical use of mitomycin C: an experimental study. Otol Neurotol 2006; 27: 4–7
  • Eken M, Evren C, Sanli A, Aydin S, Paksoy M. The effects of radiofrequency and incisional myringotomy on the duration of patency. Kulak Burun Bogaz Ihtis Derg 2007; 17: 224–7
  • Bradner WT. Mitomycin C: a clinical update. Cancer Treat Rev 2001; 27: 35–50
  • Cincik H, Güngör A, Sağlam O, Cekin E, Yildirim S, Poyrazoğlu E. Effective dose of 5-fluorouracil for myringotomy in rats. Med Sci Monit 2005; 11: 330–4
  • Yamamoto T, Varani J, Soong HK, Lichter PR. Effects of 5-fluorouracil and mitomycin C on cultured rabbit subconjunctival fibroblasts. Ophthalmology 1990; 97: 1204–10
  • Lachanas VA, Prokopakis EP, Christodoulou PN, Hajiioanou JK, Malandrakis SG, Karatzanis AD, et al. Comparative study of laser versus radiofrequency myringotomy in rabbits: the effectiveness of mitomycin C application. Otol Neurotol 2006; 27: 1162–5
  • Ragab SM. The effect of radiofrequency and mitomycin C on the closure rate of human tympanostomy. Otol Neurotol 2005; 26: 355–60
  • Jassir D, Odabasi O, Gomez-Marin O, Buchman CA. Dose response relationship of topically applied mitomycin C for the prevention of laser myringotomy closure. Otolaryngol Head Neck Surg 2003; 129: 471–4
  • Moody MW, Lang H, Spiess AC, Smythe N, Lambert PR, Schmiedt RA. Topical application of mitomycin C to the middle ear is ototoxic in the gerbil. Otol Neurotol 2006; 27: 1186–92
  • Iwanaga T, Tanaka F, Tsukasaki N, Terakado M, Kaieda S, Takasaki K, et al. Does topical application of 5-fluorouracil ointment influence inner ear function?. Otolaryngol Head Neck Surg 2006; 134: 961–5

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.